Merck & Co. said Wednesday it will acquire clinical-stage oncology company Terns Pharmaceuticals Inc. for $53 per share in cash, giving the deal an equity value of $6.7 billion.
Merck & Co. said Wednesday it will acquire clinical-stage oncology company Terns Pharmaceuticals Inc. for $53 per share in cash, giving the deal an equity value of $6.7 billion.
Guinness owner Diageo PLC said Wednesday that it is selling Indian cricket champions Royal Challengers Bengaluru to a consortium including Blackstone for 166.6 billion Indian rupees ($1.77 billion).
British infrastructure investor HICL said Wednesday that it will sell its 24% stake in a French motorway company to Spanish road toll manager Abertis for £311 million ($417 million), in order to invest the proceeds in new opportunities.
Telecoms giant Orange said Wednesday that it is in exclusive negotiations with a French investment company, Verdoso, that could lead to a sale of its media services business Globecast.
Savings and investment firm M&G PLC has said it completed a £140 million ($187 million) buy-in transaction with a pension program sponsored by electronics giant Panasonic for its employees in Europe.
Insurance giant Aviva said Wednesday that it has taken on pension liabilities worth £104 million ($139.5 million) from a retirement savings plan sponsored by Essentra PLC, in a deal steered by Squire Patton Boggs LLP.
Seascape Energy Asia PLC said Wednesday it has successfully raised £4.2 million ($5.6 million) in a share sale that the London-listed gas explorer expects will help bolster its finances.
British biotechnology company Aptamer said Wednesday that it is seeking to raise at least £3.75 million ($5 million) through the sale of shares, which the company plans to use on its projects and working capital.
Oil explorer 88 Energy Ltd. said Wednesday that it will raise up to 5.03 million Australian dollars ($3.5 million) through issuing shares in a move to strengthen its balance sheet and help finance its projects.